Jody A. Charnow

The probability of positive findings on 18F-fluciclovine positron emission tomography scans increases along with patients’ PSA levels, a single-institution study found.

Men with vs without metastases at the time they are diagnosed with prostate cancer are at higher risk of all-cause and cancer-specific mortality following onset of castration-resistant disease, a study found.

In a small study, radiation therapy directed at the primary tumor in men with metastatic castration-resistant prostate cancer was significantly associated with improved cancer-specific and overall survival.

In a phase 3 study, PSMA PET-CT was 27% more accurate than conventional imaging with CT and bone scans at detecting pelvic nodal or distant metastases in men with high-risk prostate cancer.

Single-center study reveals that robot-assisted radical prostatectomy is associated with superior biochemical recurrence-free survival and a lower positive surgical margin rate.

The adrenal-permissive HSD3B1 genotype in men with low-volume metastatic castration-sensitive prostate cancer is associated with an elevated risk of progressing to castration-resistant disease and death, a study found.